70 Participants Needed

Facing Eating Disorder Fears for Anorexia Nervosa

(FED-F Trial)

AM
CA
Overseen ByCheri A Levinson, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Louisville
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What data supports the idea that Facing Eating Disorder Fears for Anorexia Nervosa is an effective treatment?

The available research shows that addressing fears related to eating disorders, such as fear of food and weight gain, is crucial for preventing relapse after intensive treatment. One study highlights that fear of food can predict a drive for thinness, a core symptom of eating disorders, suggesting that targeting these fears can help reduce symptoms. Another study suggests that imaginal exposure therapy, which involves confronting these fears, may be more effective in preventing readmission than other interventions. This indicates that Facing Eating Disorder Fears for Anorexia Nervosa could be an effective treatment by directly addressing the fears that contribute to the disorder.12345

What data supports the effectiveness of the treatment Facing Eating Disorder Fears Condition (FED-F) for Anorexia Nervosa?

Research shows that fear and anxiety are key factors in maintaining eating disorders, and addressing these fears can help reduce symptoms. A study found that imaginal exposure therapy, which involves confronting feared situations in a controlled way, may help prevent readmission after intensive treatment by reducing fears related to food and weight gain.12345

What safety data exists for Facing Eating Disorder Fears treatment for Anorexia Nervosa?

The provided research does not directly address safety data for the Facing Eating Disorder Fears treatment for Anorexia Nervosa. However, it discusses the role of fear and anxiety in eating disorders and the potential of exposure therapy to address these fears. The pilot randomized control trial mentioned aims to test the feasibility and acceptability of an online imaginal exposure therapy, which could inform safety and efficacy in the future. Currently, there is no specific safety data available for this treatment.12367

Is the treatment Facing Eating Disorder Fears Condition a promising treatment for anorexia nervosa?

Yes, Facing Eating Disorder Fears Condition is a promising treatment for anorexia nervosa because it targets the core fears that maintain the disorder, such as fear of weight gain and social consequences. By addressing these fears, the treatment helps reduce anxiety and disordered eating behaviors, making it a valuable approach for those struggling with anorexia nervosa.13789

How is the Facing Eating Disorder Fears treatment different from other treatments for anorexia nervosa?

The Facing Eating Disorder Fears treatment is unique because it specifically targets the core fears underlying anorexia nervosa, such as fear of weight gain and social consequences, using exposure therapy techniques. This approach focuses on confronting and reducing these fears, which are key factors in maintaining the disorder, rather than just addressing the symptoms.13789

What is the purpose of this trial?

This trial tests a therapy called FED-F that helps people with Anorexia Nervosa face their fears about food, weight, and social situations. The goal is to see if this approach can reduce anxiety and prevent relapse by encouraging patients to confront their fears.

Research Team

CA

Cheri A Levinson, Ph.D.

Principal Investigator

University of Louisville

Eligibility Criteria

This trial is for adults aged 18-65 who have been diagnosed with Anorexia Nervosa (AN) or are in partial/full remission from AN, and have been discharged from intensive care like inpatient or residential treatment within the last 6 months. It's not suitable for individuals under 18, over 65, those with severe suicidal thoughts, extremely low weight, psychosis, mania, or who don't meet the criteria for AN.

Inclusion Criteria

I have been diagnosed with anorexia or atypical anorexia, including any stage of remission.
I was discharged from a hospital or intensive care unit less than 6 months ago.

Exclusion Criteria

I do not have anorexia or am not in remission from it.
Active psychosis
I am over 65 years old.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase I: Refinement and Feasibility Testing

Refine FED-F into a fully virtual format with input from patients and stakeholders and collect preliminary data on its feasibility and acceptability

Not specified
1 session of education, followed by sessions 2 through 12 of virtual treatment

Phase II: Pilot RCT

Conduct a small pilot RCT of FED-F as compared to treatment as usual (TAU)

Up to 12 sessions
Virtual treatment sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 months

Treatment Details

Interventions

  • Facing Eating Disorder Fears Condition
Trial Overview The study tests a virtual treatment called FED-F that combines exposure therapy with education and cognitive skills to help patients face fears related to food, weight gain, body perception, and social situations. The goal is to see if it's more effective than usual treatments after acute care and if it improves approach behaviors associated with relapse.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Facing Eating Disorder Fears ConditionExperimental Treatment1 Intervention
Participants will complete 1 session of education about the treatment. After completion of treatment education and baseline questionnaires, participants will complete sessions 2 through 12 of virtual treatment for anorexia nervosa and mobile assessments.
Group II: Treatment as UsualActive Control1 Intervention
Participants will complete baseline measures, mobile assessments and treatment as usual.

Facing Eating Disorder Fears Condition is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as FED-F for:
  • Anorexia Nervosa

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Louisville

Lead Sponsor

Trials
353
Recruited
76,400+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

In a study of 229 individuals with eating disorders, the most commonly reported fears were fear of gaining weight, fear of food, and fear of judgment, indicating that these fears play a significant role in maintaining eating disorder behaviors.
The research found that while there were some differences in fears based on eating disorder diagnosis and weight status, the overall heterogeneity of fears suggests that personalized assessment and treatment approaches are crucial for effective intervention.
Core eating disorder fears: Prevalence and differences in eating disorder fears across eating disorder diagnoses.Brown, ML., Levinson, CA.[2022]
Over 50% of individuals with eating disorders are likely to be readmitted to treatment within 6 months due to ongoing cognitive issues related to their disorder, highlighting the need for effective post-treatment interventions.
This pilot randomized control trial will assess the effectiveness of a five-session online imaginal exposure therapy in reducing eating disorder symptoms and fears, compared to a control writing intervention, aiming to prevent readmission and improve treatment outcomes.
A pilot randomized control trial of online exposure for eating disorders and mechanisms of change delivered after discharge from intensive eating disorder care: A registered report.Levinson, CA., Ralph-Nearman, C., Brown, ML., et al.[2023]
In a study of 63 patients with anorexia nervosa (AN) or bulimia nervosa (BN), a high prevalence of anxiety disorders was found, with 83% of AN patients and 71% of BN patients having at least one lifetime anxiety disorder, most commonly social phobia.
The majority of patients (75% of AN and 88% of BN) had their anxiety disorder develop before the onset of their eating disorder, highlighting the importance of addressing anxiety in the treatment of eating disorders.
Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance.Godart, NT., Flament, MF., Lecrubier, Y., et al.[2022]

References

Core eating disorder fears: Prevalence and differences in eating disorder fears across eating disorder diagnoses. [2022]
A pilot randomized control trial of online exposure for eating disorders and mechanisms of change delivered after discharge from intensive eating disorder care: A registered report. [2023]
Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance. [2022]
Overcoming limitations of self-report: an assessment of fear of weight gain in anorexia nervosa and healthy controls using implicit association tests. [2021]
Fear of food prospectively predicts drive for thinness in an eating disorder sample recently discharged from intensive treatment. [2018]
Fear as a translational mechanism in the psychopathology of anorexia nervosa. [2019]
Development and validation of the eating disorder fear questionnaire and interview: Preliminary investigation of eating disorder fears. [2020]
The fear of being fat and anorexia nervosa. [2006]
Imaginal Exposure for Disordered Eating Related Fears: An Initial Randomized Controlled Trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity